Cargando…

A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block

Sugammadex reverses the rocuronium-induced neuromuscular block by trapping the cyclopentanoperhydrophenanthrene ring of rocuronium. Dexamethasone shares the same steroidal structure with rocuronium. The purpose of this study was to evaluate the influence of dexamethasone on neuromuscular reversal of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koo, Chang-Hoon, Hwang, Jin-Young, Min, Seong-Won, Ryu, Jung-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230323/ https://www.ncbi.nlm.nih.gov/pubmed/32344687 http://dx.doi.org/10.3390/jcm9041240

Ejemplares similares

The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex
por: Lee, Hee Jong, et al.
Publicado: (2015)

Sensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy
por: Kashiwai, Akihiro, et al.
Publicado: (2012)

Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: A systematic review and meta-analysis
por: Won, Young Ju, et al.
Publicado: (2016)

The effect of dexamethasone on sugammadex reversal of rocuronium-induced neuromuscular blockade in surgical patients undergoing general anesthesia: A systematic review and meta-analysis
por: Lim, Byung Gun, et al.
Publicado: (2021)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013)

Reversal with sugammadex for rocuronium-induced deep neuromuscular block after pretreatment of magnesium sulfate in rabbits
por: Kang, Woon Seok, et al.
Publicado: (2017)

The effect of magnesium on the reversal of rocuronium-induced neuromuscular block with sugammadex: an ex vivo laboratory study
por: Fábián, Ákos I., et al.
Publicado: (2019)

Chronic exposure to dexamethasone may not affect sugammadex reversal of rocuronium-induced neuromuscular blockade: an in vivo study on rats
por: Park, Ha Yeon, et al.
Publicado: (2023)

Reversal of rocuronium induced neuromuscular blockade using sugammadex in a patient with eclampsia treated by magnesium intraoperatively
por: Song, Sejin, et al.
Publicado: (2014)

Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis
por: Ji, Sang‐Hwan, et al.
Publicado: (2022)

Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses
por: Ji, Sang-Hwan, et al.
Publicado: (2023)

Effect of protracted dexamethasone exposure and its withdrawal on rocuronium-induced neuromuscular blockade and sugammadex reversal: an ex vivo rat study
por: Oh, Seok Kyeong, et al.
Publicado: (2019)

Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
por: Lima Cavalcanti, Ismar, et al.
Publicado: (2020)

Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
por: Suzuki, Manzo, et al.
Publicado: (2014)

Rapid arousal from anaesthesia after reversal of deep rocuronium-induced neuromuscular block with sugammadex in a neuroradiological procedure
por: Giuffrida, Matteo, et al.
Publicado: (2021)

Sugammadex is effective in reversing rocuronium in the presence of antibiotics
por: Hudson, Mark E, et al.
Publicado: (2014)

Data and meta-analysis for choosing sugammadex or neostigmine for routine reversal of rocuronium block in adult patients
por: Hurford, William E., et al.
Publicado: (2020)

Efficacy and Safety of Sugammadex for the Reversal of Rocuronium-Induced Neuromuscular Blockade in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis
por: Kim, Young-Sung, et al.
Publicado: (2021)

Unexpected delayed reversal of rocuronium-induced neuromuscular blockade by sugammadex: A case report and review of literature
por: Wang, Hao-Chen, et al.
Publicado: (2022)

Comparison of the Efficacy and Safety of Adamgammadex with Sugammadex for Reversal of Rocuronium-Induced Neuromuscular Block: Results of a Phase II Clinical Trial
por: Jiang, Yingying, et al.
Publicado: (2022)

Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex -a case report-
por: Kim, Gunn Hee, et al.
Publicado: (2019)

Efficacy and safety of sugammadex sodium in reversing rocuronium-induced neuromuscular blockade in children: An updated systematic review and meta-analysis
por: Zhou, Sheng, et al.
Publicado: (2023)

Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report
por: Kim, Ji Eun, et al.
Publicado: (2017)

A retrospective study of sugammadex for reversal of neuromuscular blockade induced by rocuronium in critically ill patients in the ICU
por: Bologheanu, Răzvan, et al.
Publicado: (2022)

Repeat dosing of rocuronium-sugammadex: unpredictable
por: Kim, Yoon-Hee
Publicado: (2014)

Sugammadex and rocuronium-induced anaphylaxis
por: Takazawa, Tomonori, et al.
Publicado: (2015)

Treatment of rocuronium-induced anaphylaxis using sugammadex - A case report -
por: Kim, Sun-Min, et al.
Publicado: (2021)

Effects of age on sugammadex reversal of neuromuscular blockade induced by rocuronium in Chinese children: a prospective pilot trial
por: Zhang, Ruidong, et al.
Publicado: (2021)

A temporary decrease in twitch response following reversal of rocuronium-induced neuromuscular block with a small dose of sugammadex in a pediatric patient
por: Iwasaki, Hajime, et al.
Publicado: (2013)

Dexamethasone does not diminish sugammadex reversal of neuromuscular block – clinical study in surgical patients undergoing general anesthesia
por: Rezonja, Katja, et al.
Publicado: (2016)

Use of rocuronium and sugammadex under neuromuscular transmission monitoring in a patient with multiple sclerosis
por: Staikou, Chryssoula, et al.
Publicado: (2017)

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
por: Aouad, Marie T., et al.
Publicado: (2017)

Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade
por: Kim, Kyo Sang, et al.
Publicado: (2016)

Rocuronium-induced neuromuscular block after long pretreatment of clonidine in rabbits
por: Koo, Min Seok, et al.
Publicado: (2010)

Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
por: Choi, Shu Chung, et al.
Publicado: (2020)

Effect of ulinastatin on the rocuronium-induced neuromuscular blockade
por: Kim, Min Soo, et al.
Publicado: (2012)

Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
por: Wefki Abdelgawwad Shousha, Ahmed Abdelgawwad, et al.
Publicado: (2014)

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
por: Schaller, Stefan Josef, et al.
Publicado: (2013)

Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
por: Carlos, Ricardo Vieira, et al.
Publicado: (2017)

Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery
por: Alsaeed, Abdulhamid, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_le7hvutbni7f2kpeupgm068bta